Latest filing published 23 Aug 2022 for LeanLife Health Inc., €25k.
No signal scores available.
This profile gathers the share dealings of James Casey Dalton Forward in LeanLife Health Inc. The record holds 9 filings, for trades running from 15 April 2020 to 8 June 2021.
Sales make up the whole of the open-market record (4 sales, €59k). Besides market trades, the filings include 2 share grants and 2 option exercises. Since January 2022: no purchases and 4 sales on the market.
The newest entry dates from 23 August 2022: an option exercise of €25k, in LeanLife Health Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations